Singota Solutions Expands European Footprint with New Pallet Storage Facility
Singota Solutions has expanded its European footprint by opening a state-of-the-art -40°C and -20°C pallet storage facility near Milan, Italy. This new facility in Rovello Porro enhances Singota’s service offerings with advanced temperature-controlled storage options, critical for maintaining the stability and efficacy of modern pharmaceutical products. The expansion underscores Singota’s commitment to meeting stringent regulatory requirements and providing unparalleled logistics and 3PL solutions to its clients.
William Carlin
07 Aug 2024 2:58 PM
New State-of-the-Art Storage Facility
Singota Solutions, a leading Contract Development and Manufacturing Organization (CDMO), has expanded its service offerings by establishing a new -40°C and -20°C pallet storage facility near Milan, Italy. This strategic expansion reinforces Singota's commitment to providing exceptional logistics and 3PL solutions globally.
Enhancing European Presence
Building on Singota’s existing presence in Switzerland, the new facility in Rovello Porro, Italy, significantly strengthens the company's European depot network. Situated in a free-trade zone, this site is certified to Italian Medicines Agency (Agenzia Italiana del Farmaco/AIFA) standards, ensuring high-quality and compliant operations. The facility's accreditation highlights Singota's dedication to meeting stringent regulatory requirements essential for the safe and efficient handling of pharmaceutical products.
Advanced Storage Capabilities
The Rovello Porro facility offers a wide range of temperature-controlled storage options designed to meet the diverse needs of modern pharmaceutical products, including:
- Room Temperature Storage (15-25°C)
- Cold Storage (2-8°C)
- Frozen Storage (-20°C)
- Low Temperature Storage (-40°C)
The -40°C pallet storage capability is particularly notable, catering to new biologic products that require low temperatures to maintain stability and efficacy. This specialized storage solution sets Singota apart, providing clients with a rare and highly sought-after service.
Strategic Benefits
Located within the European Union, the Rovello Porro facility offers significant strategic advantages for Singota's clients. Many regulatory requirements necessitate an EU presence, and this new location ensures Singota can meet these needs. The bonded, free-trade zone status further enhances its appeal, offering clients streamlined logistics and reduced customs complexities.
Client-Centric Expansion
Singota Solutions' expansion into Rovello Porro demonstrates its commitment to supporting clients through every phase of the drug development pipeline. This new facility not only expands the company's geographical reach but also enhances its service offerings to include cutting-edge storage capabilities crucial for the next generation of biologic products.
About Singota Solutions
Singota Solutions is a CDMO dedicated to overcoming obstacles in the drug development pipeline. Specializing in small-batch aseptic filling, aseptic manufacturing solutions, and injectable formulation development, Singota offers comprehensive services designed to expedite the progression of clients' products toward clinical trials. The company's GMP-compliant warehousing and 3PL operations ensure the integrity and safety of pharmaceutical products, including those requiring cold-chain pharmaceutical storage.
The expansion of supply chain operations in Italy marks a significant milestone in Singota's mission to deliver unparalleled support to clients, helping them navigate the complex pharmaceutical landscape with confidence and precision.
Processing Request